298 related articles for article (PubMed ID: 10508818)
1. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Shibusa T; Shijubo N; Abe S
Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466
[TBL] [Abstract][Full Text] [Related]
4. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
[TBL] [Abstract][Full Text] [Related]
8. Different angiogenic pathways in human cervical cancers.
Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative study of vascular endothelial growth factor expression in primary lung cancer].
Shi E; Jiang H; Xu S
Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):596-8. PubMed ID: 11715407
[TBL] [Abstract][Full Text] [Related]
10. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
12. Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis.
Fujimoto K; Abe T; Müller NL; Terasaki H; Kato S; Sadohara J; Kono R; Edamitsu O; Ishitake T; Hayashi A; Rikimaru T; Hayabuchi N
Radiology; 2003 Jun; 227(3):786-93. PubMed ID: 12714678
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
Fontanini G; Boldrini L; Chinè S; Pisaturo F; Basolo F; Calcinai A; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Br J Cancer; 1999 Jan; 79(2):363-9. PubMed ID: 9888482
[TBL] [Abstract][Full Text] [Related]
14. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Kojima H; Shijubo N; Abe S
Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
[TBL] [Abstract][Full Text] [Related]
16. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
[TBL] [Abstract][Full Text] [Related]
19. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.
Imada A; Shijubo N; Kojima H; Abe S
Eur Respir J; 2000 Jun; 15(6):1087-93. PubMed ID: 10885428
[TBL] [Abstract][Full Text] [Related]
20. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
Volm M; Koomägi R; Mattern J
Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]